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Abstract: In most low- and middle-income countries,
child mortality is estimated from data provided by
mothers concerning the survival of their children using
methods that assume no correlation between the
mortality risks of the mothers and those of their children.
This assumption is not valid for populations with
generalized HIV epidemics, however, and in this review,
we show how the United Nations Inter-agency Group for
Child Mortality Estimation (UN IGME) uses a cohort
component projection model to correct for AIDS-related
biases in the data used to estimate trends in under-five
mortality. In this model, births in a given year are
identified as occurring to HIV-positive or HIV-negative
mothers, the lives of the infants and mothers are
projected forward using survivorship probabilities to
estimate survivors at the time of a given survey, and the
extent to which excess mortality of children goes
unreported because of the deaths of HIV-infected
mothers prior to the survey is calculated. Estimates from
the survey for past periods can then be adjusted for the
estimated bias. The extent of the AIDS-related bias
depends crucially on the dynamics of the HIV epidemic,
on the length of time before the survey that the estimates
are made for, and on the underlying non-AIDS child
mortality. This simple methodology (which does not take
into account the use of effective antiretroviral interven-
tions) gives results qualitatively similar to those of other
studies.
Introduction
HIV/AIDS is different from many causes of mortality in that
people are primarily infected and subsequently die during their
peak reproductive period. In countries with generalized HIV
epidemics, taken here as having a prevalence that reaches 5% of
the adult population, HIV incidence peaks among women in their
mid-20s and among men approximately five years older. Given an
average survival time of around ten years in the absence of
antiretroviral therapy (ART), this means that, prior to the
widespread use of ART, AIDS mortality in countries with
generalized HIV epidemics peaked around age 30–35 years in
women and around five years older for men [1]. For these
countries, all of which are in sub-Saharan Africa, AIDS is the
leading cause of mortality among adults of reproductive age (15–
49 years old) [2]. A study conducted early in the epidemic
calculated that in the countries of southern Africa with HIV
prevalence over 10% [3], almost half of all adults in the 15-year-
old cohort would die due to AIDS, and population growth would
cease [4].
A second unique feature of HIV/AIDS is the transmission of
HIV from infected mothers to their children. Prior to widespread
use of ART, infected children were almost certain to die in
childhood, thus introducing a strong correlation between mortality
risks of mothers and their children.
In this review, we discuss how this combination of high
prevalence, high mortality, and a correlation between the
mortality risks of mothers and their children has a major impact
on the data used to estimate the under-five mortality rate (the
probability of dying between birth and age five years, also denoted
in the literature as U5MR and 5q0). We review the approach
currently being used by the United Nations Inter-agency Group
for Child Mortality Estimation (UN IGME) to adjust for bias due
to AIDS in child mortality estimation (CME) in countries where
the prevalence of HIV/AIDS has reached 5% or above in the
adult population. We discuss the impact this adjustment has on
estimates of under-five mortality and conclude by discussing future
plans within UN IGME to expand this procedure and to improve
the accuracy of the adjustment for the estimation of trends in
under-five mortality in countries with a significant HIV epidemic.
Why Does AIDS Mortality Bias Child Mortality
Estimates?
Estimates of child mortality for populations lacking accurate
registration of births and deaths (in practice, most low- and
middle-income countries) are derived almost entirely from reports
of mothers of reproductive age about the survival of their children.
The most common approach to the collection of the data needed
for CME—the collection method used in all surveys by the
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surveys by the Multiple Indicator Cluster Surveys program—
involves taking full birth histories. In such histories, each woman
aged 15 to 49 years at the time of the survey is asked for the date of
birth of each live-born child she has had, and, if the child has died,
the age at death. Child mortality is directly estimated from the
information on births and deaths for periods up to 25 years before
the survey. The births on which data are collected must be
representative of all the births in the population for the entire
period to allow valid estimates of population-level child mortality
to be made. It is unlikely that this condition is ever perfectly met:
births to mothers who have died or migrated out of the population
will not be reported. Moreover, for periods long before the survey,
births to older mothers will not be represented because these
mothers will have been age 50 or over at the time of the survey
and therefore not included. It is normally assumed that any bias
introduced by lack of representativeness is small, but this will not
be the case in populations substantially affected by HIV, where
HIV-positive children will be more likely to die than other
children, and their deaths will be less likely to be reported since
their mothers will have also been more likely to die. Direct child
mortality estimates will thus be biased downwards in regions
affected by a generalized HIV epidemic [5–8].
The second most common approach to the collection of data for
CME involves collecting summary birth histories. Many develop-
ing country population censuses and household surveys, as well as
most surveys by the Multiple Indicator Cluster Surveys program,
collect summary birth histories. Each woman 15 to 49 years old at
the time of the survey is asked how many live-born children she
has had and how many of them are still alive. Indirect estimates of
child mortality are then derived covering the ten- to 15-year
period before the survey from proportions dead of children ever
born classified by five-year age groups of mothers through the use
of fertility and mortality models [5]. As with full birth histories,
mothers of high-risk HIV-infected children are less likely to report
because of their own HIV-related mortality, and, as a conse-
quence, child mortality estimates are again biased downwards.
Although migration and selective nonresponse for other reasons
may introduce bias, the greatest threat to child mortality estimates
based on reports of women about the survival or death of their
children currently arises from generalized HIV/AIDS epidemics.
Vertical transmission of HIV from mother to child during
pregnancy and delivery, and through breastfeeding in the first
few months of life, increases the risk that the child will be HIV-
positive by as much as 35% in the absence of ART, and over 60%
of HIV-positive children will die before their fifth birthday in the
absence of ART treatment [9–11]. Since the mothers also suffer
elevated mortality risks, the deaths of many of these HIV-positive
children, particularly those born five years or more before
interview, will not be reported. Overall child mortality will
therefore be underestimated, whether using direct or indirect
CME methods.
How Can the Effects of AIDS Mortality on Direct
CME Be Calculated?
To our knowledge, only one analysis of the magnitude of bias in
direct child mortality estimates due to AIDS mortality has been
carried out using real data rather than simulations. Hallett et al.
[8] used data from a prospective open cohort in Manicaland,
Zimbabwe, to measure the bias introduced by deaths of HIV-
positive mothers. The cohort was interviewed between July 1998
and February 2000, with follow-up interviews at three and five
years; at each interview round, child deaths since the previous
round were recorded. From 1998 to 2005, HIV prevalence in the
study population fell from 22% to 18%. In the final interview
round in 2005, a full birth history was collected from the surviving
women, and U5MR was estimated for the period 1998 to 2005, a
seven-year period as opposed to the five-year periods usually used
for DHS estimates. The direct estimates were then compared to
true values, adding back the child mortality experience of women
who had died before 2005. The bias, calculated as the estimates
from reports by surviving mothers divided by the estimates for all
mothers, was 6.7% for the infant mortality rate (the probability of
death before age one year) and 9.8% for the U5MR. The analysis
indicated that bias in direct estimates increases with the duration
of the epidemic and with the time before survey of the estimate,
but decreases as the level of background non-HIV child mortality
increases. Hallett et al. also developed a model of bias, which they
applied to Zimbabwe and six other countries with moderate or
high HIV prevalence for the period 1980 to 2015 using Joint
United Nations Programme on HIV/AIDS (UNAIDS) prevalence
data and DHS estimates for pre-epidemic periods. Thus, the
Hallett et al. analysis only directly estimates bias for the five-year
period before a survey; estimates for earlier periods are model-
based.
The UN IGME Approach to Bias Adjustment in
Populations with a Generalized HIV Epidemic
Based on the findings of Hallett et al. [8], UN IGME [12]
recently implemented an adjustment approach for use in countries
where prevalence of HIV/AIDS has reached 5% or above in the
adult population (ages 15–49 years). Because precise estimation of
the bias in reported U5MR due to HIV would require a great deal
of information about the HIV epidemic that is not typically
available (for example, details on the distribution of births to HIV-
positive women by the duration of infection, vertical transmission
rates, and survival times of both mothers and children from the
time of the birth), UN IGME has adopted a number of
simplifications.
The UN IGME approach uses a simple cohort component
projection model that is implemented in a customized Excel
workbook and that starts with the latest projection of a national
population and its HIV epidemic from UNAIDS [3]. The HIV/
AIDS projections are made using Spectrum population projection
software [11] and combine data on HIV prevalence and a
resulting incidence curve with assumptions about many factors,
such as survival time with and without treatment and age-and sex-
specific prevalence, to produce an estimate of the complete course
of the epidemic from its start to the current date. The Spectrum
output provides the annual number of births, typically from 1970
onwards, the number of women each year in need of prevention of
mother-to-child transmission (taken as a proxy for the number of
births to HIV-positive women), and the number of HIV-positive
infants. The input data for the UN IGME model are taken directly
from the Spectrum output and thus take into account the fertility-
reducing effects of HIV and the estimated transmission of HIV
from mother to child. The Spectrum model also takes into account
breastfeeding patterns and the impact of various interventions to
prevent mother-to-child transmission in its estimation of the
number of children infected with HIV.
For each year, the births are divided into three streams: HIV-
negative births to HIV-negative mothers, HIV-negative births to
HIV-positive mothers, and HIV-positive births to HIV-positive
mothers (no distinction is made between children infected at or
before birth and those infected after birth). For births in each year,
deaths under age five in the subsequent five years are calculated
for each stream. For both categories of HIV-negative births, risks
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model life table (the Coale and Demeny ‘‘West’’ family [13]) with
a U5MR approximating a best guess of the U5MR in the HIV-
negative population, referred to as the background U5MR. The
simplifying (and somewhat unrealistic) assumption is made that the
mortality risks of HIV-negative children are the same regardless of
the HIV status of the mother. For HIV-positive births, the model
uses a mortality schedule derived by averaging results from cohort
studies [9–11], with a probability of dying by age five of 62.5%, to
provide risks of dying in each year from birth to age five; it is
assumed that ART treatment had no effect on these risks until
after 2007.
From this series of steps, the model provides estimates of ‘‘true’’
births and under-five deaths for each calendar year. The next step
is to estimate how many of these births and under-five deaths will
go unreported at a particular survey because of the deaths of
mothers. To do this, the UN IGME model first assumes that HIV-
negative women have negligible mortality risks over the short time
frame involved, so all their births and under-five deaths are
reported. It then makes the further simplifying assumption that
births to HIV-positive women occur to women four years after
infection (four years was chosen on the grounds that births to HIV-
positive women are skewed towards the beginning, rather than the
end, of their infected life). A survival curve from first infection,
again derived from cohort studies [9–11], with a median survival
time of about 9.5 years, is used to create a survival curve from four
years after infection, from which the probabilities of surviving from
a particular year to the year of a given survey (assumed to be at the
end of a year) is obtained. These curves are then used to estimate
the proportion of the births and child deaths (whether HIV-
negative or HIV-positive) of HIV-positive mothers that would
have been reported by the survey if all of the mothers had survived
to the time of the survey.
For each five-year period before a survey, the ‘‘true’’ and the
‘‘reported’’ births and under-five deaths are summed; the five-year
periods used are 1–5, 6–10, and 11–15 years before the survey to
reduce the impact of the ‘‘displacement effect’’ often found in
DHS datasets, a tendency to shift births backwards in time from
four years before the survey to five years before [14]. The
estimated bias for each period is calculated as 1.0 minus the
‘‘reported’’ ratio of under-five deaths to births (reported by women
still alive at the survey) to the corresponding ratio that would have
been observed had none of the mothers died. Finally, survey
estimates of under-five mortality are adjusted by dividing by
1.0 minus the estimated bias for each period. Box 1 provides a
simplified example of this process.
Once the adjusted estimates of U5MR have been made, they
are used as the inputs into the UN IGME fitting approach that is
used to develop the trends and current point estimates of U5MR
for all low- and middle-income countries [15]. The fitting
approach is described in detail in another paper in the 2012
PLOS Medicine Collection ‘‘Child Mortality Estimation Methods’’
[14]; the adjusted and unadjusted datasets and country-specific
data fits are all available in the CME Info database (http://www.
childmortality.org). Importantly, the fitting approach used for
countries with HIV epidemics is different from that used for those
without, and can be summarized as follows. First, the bias-adjusted
U5MR estimates are calculated from each DHS survey. Second,
HIV deaths for each period as estimated by UNAIDS are
subtracted to obtain non-HIV U5MR estimates. Third, a loess
curve is fitted to the non-HIV U5MR estimates to obtain a smooth
time sequence. Finally, the HIV deaths by period are added back
to obtain the final adjusted U5MR series [14].
A detailed example of the adjustment procedure for Zambia in
2007 is available in Protocol S1. Figure 1 shows the different best
fitting trends in under-five mortality for Zambia, using the
unadjusted and adjusted datasets. Zambia is a good example, as
there have been four DHS surveys that used direct methods for
childhood mortality measurement (1992, 1997, 2002, and 2007),
and the estimates of adult HIV prevalence for Zambia have been
above 10% since the mid-1990s [3]. As can be seen in Figure 1, the
deviation between the unadjusted and adjusted curves starts in the
mid-1980s in Zambia, the period after the presumed start of the
HIV/AIDS epidemic in the country, when AIDS mortality
becomes an issue. Prior to that period, the curves are identical, as
there is no adjustment for AIDS mortality. The two curves converge
at the end, as there is only one recent data point (from the 2007
DHSsurvey)andtheadjustmentfortherecent recallperiodissmall.
How Big Should the Bias Adjustment Be?
Table 1, which was prepared using the UN IGME model
described above, shows estimates of bias for six countries in sub-
Saharan Africa based on DHS data collected around the middle of
the last decade, before ART was widely available, for time periods
Box 1. An Example of How the UN IGME
Cohort Component Projection Model Works
for a Survey Conducted in 2005
N We assume the survey was conducted at the end of 2005
and consider births that occurred in 1995. Spectrum
provides the number of such births, the number of
women in 1995 in need of services to prevent mother-
to-child transmission (a proxy for the number of births to
HIV-positive women), and the HIV status of infants that
year (assumed equal to incidence among that year’s
births).
N From these figures, we derive the number of births to
HIV-negative and HIV-positive women.
N Births to HIV-positive women are then subdivided as per
Spectrum output into those that will, and those that will
not, become infected with HIV, reflecting breastfeeding
patterns and prevention of mother-to-child transmission
interventions.
N We estimate an appropriate U5MR for HIV-negative
births (largely from estimates prior to the epidemic), let’s
say, 150 per 1,000 live births. Under-five deaths will
occur in the period 1995–2000, by which time all the
surviving children will have reached age five. All the
births and under-five deaths to HIV-negative women will
be reported, but few of the births and deaths (regardless
of the serostatus of the child) to HIV-positive mothers
will be reported (the ten-year survival probability from
four years after infection in our model is only 14%).
N This process is repeated for all birth cohorts from 1990 to
2005. True births and under-five deaths, and reported
births and under-five deaths, are summed for the
periods 2000–2004, 1995–1999, and 1990–1994 (corre-
sponding to 1–5, 6–10, and 11–15 years before the
survey, and starting at one year before the survey to
minimize the birth displacement found in many DHS
surveys). For each period the ratio of reported propor-
tion dead to true proportion dead is calculated.
N Finally, survey estimates of U5MR for each period are
adjusted by dividing the observed values by 1.0 minus
the ratio just calculated.
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table that the extent of bias depends on the HIV prevalence and its
past trajectory, the level of background U5MR, and the time
period before the survey to which the estimate refers. The Hallett
et al. analysis [8], which is based on actual data, reaches the same
conclusions. Although Table 1 provides a general guide to the size
of bias adjustment likely to be needed, it clearly indicates that it is
not possible to provide a simple way to assess the magnitude of
bias. It is also important to remember in interpreting these results
that bias is a function of non-HIV-related child mortality, which is
not easy to estimate, and HIV prevalence, which is usually
estimated with error. Notably, however, Table 1 shows that bias is
highest for the period 6–10 years before the survey and is 10% or
more if the HIV prevalence exceeds 5%. The highest bias (26%)
was estimated for Zimbabwe, which has a high HIV prevalence
and moderate background mortality.
Application of Methods to Adjust for Bias due to
AIDS
The 2010 round of estimates from UN IGME [15] was the first
set of estimates that used the systematic approach described above
to adjust for known biases due to AIDS mortality in the direct
methods of measuring U5MR. In all, adjustments were made for
17 countries and 49 surveys. All the datasets for U5MR, including
the adjusted datasets where appropriate, are available in the CME
Info database (http://www.childmortality.org). This publicly
available database offers the opportunity for national programs
and researchers to access the datasets and to try different fitting
approaches online.
While we believe the use of the adjusted datasets has improved
the estimates of U5MR in countries where there is a generalized
HIV epidemic, the methodology makes a number of simplifying
assumptions. In particular, it makes the following key assumptions.
(i) It assumes that HIV-negative children of HIV-positive mothers
experience the same background mortality as children of HIV-
negative mothers. This is unlikely to be correct; there is evidence
that such children also suffer excess mortality, though not from
HIV. To the extent that this is the case, the methodology will
underestimate bias. (ii) The model does not distinguish the survival
prospects of those infected before or at birth from those infected
through breastfeeding. (iii) The methodology assumes that births
to HIV-positive women all occur four years after infection, with
correspondingly shortened survival times for the mothers. We have
no insight as to which direction this simplification might affect
estimates of bias. (iv) Related to assumption iii, the methodology
does not account adequately for the early dynamics of an
epidemic, when a large proportion of HIV-positive mothers are
Figure 1. Best fitting trends by year in U5MR using adjusted direct datasets compared to unadjusted datasets.
doi:10.1371/journal.pmed.1001298.g001
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overestimate bias for the first few years of an epidemic. (v) The
methodology assumes that HIV-negative women experience no
mortality. This is the same assumption as the ‘‘no selection bias’’
assumption made in standard analyses of birth histories. Our
hypothesis is that this assumption may lead to a slight overrep-
resentation of HIV-negative women in the estimates, and therefore
a slight overestimate of bias. (vi) The methodology assumes we can
adequately estimate background non-AIDS U5MR. (vii) Finally,
the current model makes no adjustment for ART. As therapies
become more widespread, the excess U5MR of children of HIV-
positive women will decline, and the mortality of their mothers will
also decline, so any bias will decline. The effect of treatment on
bias in surveys conducted prior to 2008 should be small, but going
forward we will need a methodology that takes into account the
dynamics of infection and treatment.
Table 1 compares our estimates of bias with the estimates
previously modeled by Hallett et al. [8]. In all cases, our biases are
larger, often by a substantial margin (double in the case of Namibia).
Importantly, however, the rank ordering of countries by bias is almost
identical. One reason our estimates are higher may be that our time
periods are for the early 2000s, whereas Hallett
et al.’s are for the late 2000s; another reason may be that we assume
lower background non-HIV child mortality, but this could explain
only a small proportion of the differences. The case of Namibia is
particularly marked: the country has high HIV prevalence and low
background mortality, yet relatively small bias as estimated by Hallett
et al. [8]. Our estimate of bias for this country may be considerably
higher than that provided by the Hallett et al. model because of
assumption iv above—the HIV epidemic in Namibia is younger than
that in some other countries considered in Table 1.
Given the large and continuing uncertainty about the dynamics of
the HIV epidemic, we contend that simplifying assumptions are
justified for the purpose at hand. Ultimately, of course, rather than
complex models with many parameters, it is desirable to have more
empirical estimates of bias based upon surveillance sites, such as those
of Hallett et al. [8]. It should also be borne in mind that the adjustment
f o rb i a si nd i r e c tC M E si so n l yo n ep a r to ft h eo v e r a l la d j u s t m e n t .A s
explained earlier,once a direct survey-based U5MR estimate hasbeen
adjusted for HIV bias, it is adjusted again to approximate an AIDS-
free value on the basis of the UNAIDS-estimated number of AIDS
deaths of children under five. The loess curve is then fitted to all the
available estimates of AIDS-free U5MR, including those for time
periods prior to the epidemic. Under-five AIDS deaths are then added
back to the AIDS-free trajectory of U5MR to get final estimates.
There is substantial variation in estimates of under-five AIDS deaths
for a given year from one UNAIDS revision to the next; the
adjustment for birth history bias, therefore, is not the only source of
substantial uncertainty in the final estimates.
Future Prospects
We do not regard the current UN IGME approach as a
‘‘finished product.’’ Rather, it is a work in progress. In particular,
bearing in mind the fact that this approach makes no allowance for
the evolution of the AIDS epidemic (see assumptions iv and vii
above), we plan to add refinements that will improve the
adjustment methods. One major change we are currently working
on is to switch to using estimates of incidence cohorts instead of
prevalence cohorts from the UNAIDS models of HIV/AIDS.
Beginning with the 2010 round of estimates, the Spectrum
package can now produce a historical trend of incident cohorts for
mothers and children [11]. This output will allow for a better
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should improve the accuracy of the adjustment approach.
The use of incident cohort outputs from Spectrum will also
allow direct adjustment for the impact of prevention of mother-to-
child transmission programs, and ART for mothers and children.
This is important because ART use to prevent mother-to-child
transmission and to extend survival times will have a quick effect
on reducing bias for the most recent time period before a survey,
though bias for past time periods will persist for a decade or more
after effective therapy is introduced because infected mothers will
have already died. In the current methods we have maternal and
child deaths by time (all adjusted for prevention of mother-to-child
transmission programs and treatment), but then have to estimate
the distribution of those deaths into mother and child pairs. Using
the new outcomes from Spectrum, we will be able to make the
adjustment without this step.
UN IGME is also investigating the use of an adjustment
technique that could be applied to indirect estimates of under-five
mortality based on summary birth histories. Such a technique is not
currently available for rapidly changing epidemics, but fortunately
most ofthecountrieswith anadult HIVprevalencegreaterthan 5%
conduct surveys with full birth histories with reasonable frequency.
Indirect estimates of under-five mortality based on summary birth
history data are based on assumptions that include the major one
underlying directestimationfrom full birth histories (low correlation
between probability of death of the mother and child). To date,
there have been at least two studies that have used simulations to
estimate the impact that various levels of adult HIV prevalence
would have on indirect estimates of under-five mortality [7,16].
Both analyses suggest that at higher prevalence levels and with
reports from older mothers, the bias could be considerable.
Importantly, however, the correction approach for the bias
developed by Ward and Zaba is based on the assumption that the
epidemic is stable [7], that is, it assumes that HIV prevalence is not
changing over time. Clearly, this assumption is not appropriate for
most if not all of the HIV epidemics in countries in sub-Saharan
Africa. UN IGME and its Technical Advisory Group are therefore
working on ways to build on this model in order to develop
adjustment factors for the AIDS-related bias in surveys that have
only indirect measures of child mortality.
Supporting Information
Protocol S1 Spreadsheet to estimate AIDS bias in full
birth history estimates of child mortality: example
application to Zambia 2007.
(XLS)
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